
MENS vs BGM
$MENS vs $BGM head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MENS vs BGM: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+7%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: MENS -95.1% and BGM -96.7%, against the S&P 500 at +7%.
- ·BGM has support 1.1% below at $7.91; MENS has no tested support within 35% under its price.
- ·MENS is within 0.5% of resistance at $1.65, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
MENS vs BGM: the quick read
- ·MENS is the larger company by market cap ($110M vs $107M).
- ·BGM has the smaller float (13.0M vs 25.3M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·MENS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·MENS is the one in play today, trading about 2.1x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching MENS or BGM? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MENS and BGM on TheDesperateTrader.
- Is MENS or BGM the better stock?
- "Better" depends on your goal, and these two are not alike. MENS is the larger company by market cap ($110M vs $107M). BGM has the smaller float (13.0M vs 25.3M), which tends to mean sharper, more volatile moves. Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MENS and BGM?
- The differences that matter: they are similar in size ($110M vs $107M); they trade at very different share prices ($1.64 vs $8.00); MENS sits at 1% of its 52-week range against 74% for BGM. Everything above is measured from the latest completed session and SEC filings.
- Which of MENS and BGM is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is MENS or BGM in the stronger trend?
- MENS is below its 50-day average of $1.95 and below its 200-day average of $2.08; BGM is below its 50-day average of $8.44 and below its 200-day average of $15.58. MENS leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MENS or BGM? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.